A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. - Iwashita,Y.; Tahara,K.; Goto,S.; Sasaki,A.; Kai,S.; Seike,M.; Chen,C.L.; Kawano,K.; Kitano,S. (Cancer Immunol Immunother, 2003)